Osteoporosis News

A study published in the European Journal of Human Genetics has detailed how women with a faulty gene demonstrate lower bone mass and nine-fold bone loss over women who have a correct copy of the gene.

An increased awareness of comorbidities and their impact upon fracture risk may help improve upon fracture-prediction algorithms, according to a study published in Bone.

Investigators have identified 56 genetic variants that influence bone mineral density, according to a study published in Nature Genetics.

The bisphosphonate alendronate sodium increases bone mineral density in patients with immunobullous diseases and glucocorticoid-induced osteoporosis, according to study results.

The FDA has approved the first generic versions of the bisphosphonate ibandronate, a once-monthly tablet for the treatment or prevention of osteoporosis in postmenopausal women.

Hip bone size, shape, strength and mineralization can be predicted by bone growth characteristics in the first years of life, a finding that may prove useful to clinicians reduce the risk of osteoporosis later in life, according to a study by U.K. researchers that they presented at the recent European Congress on Osteoporosis & Osteoarthritis in Bordeaux, France.

Researchers from the European Congress on Osteoporosis and Osteoarthritis have concluded that the cost of preventing and treating fragility fractures is a bigger economic burden on the European Union than once thought, with incident hip fractures posing the greatest burden, according to a study published in Osteoporosis International.

A 63-nation study of country-specific risk of hip fracture and 10-year probability of major fragility fractures has revealed a large geographic variation in fracture risk, according to findings published in Osteoporosis International.

The use of telephone intervention that included motivational interviewing did not show a statistically significant improvement in adherence to osteoporosis medication among Medicare beneficiaries, according to data from a randomized controlled trial.

Although a recent study in the New England Journal of Medicine suggests women with normal results on dual-energy X-ray absorptiometry scans at age 67 years and older may wait as much as 15 years for a second test, some physicians have cautioned such an interval is inappropriate for many adults.